Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
111.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
112.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
0.5 mg/kg/injection |
97.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
116.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
167.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
1.0 mg/kg/injection |
132.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
130.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
166.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
2.0 mg/kg/injection |
161.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX009 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
8.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 06/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
8.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 6 |
Q01DX009 (ip) |
median survival time |
saline |
8.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |